| Mrs Stephanie Catherine Marchesi, CRNP | |
|
5230 Centre Ave, Pittsburgh, PA 15232-1304 | |
| (412) 623-2121 | |
| Not Available |
| Full Name | Mrs Stephanie Catherine Marchesi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 5230 Centre Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477103224 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | SP020751 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wheeling Hospital | Wheeling, WV | Hospital |
| Reynolds Memorial Hospital | Glen dale, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wheeling Hospital Inc | 5799689493 | 319 |
News Archive
The publication of the systematic review of intensive insulin therapy in hospitalized patients and the American College of Physicians (ACP) clinical guidelines for inpatient glucose control in the February 15th issue of Annals of Internal Medicine has again raised the issue of optimal management of hyperglycemia in the hospital.
Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived longer without their disease worsening (progression-free survival or PFS) than those who did not continue to receive Rituxan.
The level of public acceptance of evolution in the United States is now solidly above the halfway mark, according to a new study based on a series of national public opinion surveys conducted over the last 35 years.
World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.
The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.
› Verified 7 days ago
| Entity Name | Wheeling Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104821305 PECOS PAC ID: 5799689493 Enrollment ID: O20031124000706 |
News Archive
The publication of the systematic review of intensive insulin therapy in hospitalized patients and the American College of Physicians (ACP) clinical guidelines for inpatient glucose control in the February 15th issue of Annals of Internal Medicine has again raised the issue of optimal management of hyperglycemia in the hospital.
Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived longer without their disease worsening (progression-free survival or PFS) than those who did not continue to receive Rituxan.
The level of public acceptance of evolution in the United States is now solidly above the halfway mark, according to a new study based on a series of national public opinion surveys conducted over the last 35 years.
World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.
The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Stephanie Catherine Marchesi, CRNP 339 Trinity Dr, Washington, PA 15301-5723 Ph: (614) 257-9144 | Mrs Stephanie Catherine Marchesi, CRNP 5230 Centre Ave, Pittsburgh, PA 15232-1304 Ph: (412) 623-2121 |
News Archive
The publication of the systematic review of intensive insulin therapy in hospitalized patients and the American College of Physicians (ACP) clinical guidelines for inpatient glucose control in the February 15th issue of Annals of Internal Medicine has again raised the issue of optimal management of hyperglycemia in the hospital.
Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived longer without their disease worsening (progression-free survival or PFS) than those who did not continue to receive Rituxan.
The level of public acceptance of evolution in the United States is now solidly above the halfway mark, according to a new study based on a series of national public opinion surveys conducted over the last 35 years.
World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.
The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.
› Verified 7 days ago
Christian Lima, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Delafield Rd, Suite 313, Pittsburgh, PA 15215 Phone: 412-781-0400 | |
Brianne Leigh Wehner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Forbes Ave 3rd Floor Gumberg, Pittsburgh, PA 15282 Phone: 412-396-1650 | |
Gorka Murga, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2310 Jane St, Pittsburgh, PA 15203 Phone: 412-586-1755 | |
Bruce Richard Kelly, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Guys Run Road, Pittsburgh, PA 15238 Phone: 412-435-0005 Fax: 412-435-0003 | |
Dr. John Joseph Danek, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 575 Coal Valley Road, Suite 502, Jefferson Regional Medical Center, Pittsburgh, PA 15236 Phone: 412-469-5983 Fax: 412-469-5946 | |
Dr. William E Chelen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 Marion St., Pittsburgh, PA 15219 Phone: 412-232-3555 | |
Valerie Wislo, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7175 Saltsburg Rd, Pittsburgh, PA 15235 Phone: 412-795-7366 |